Ginkgo Bioworks Holdings (DNA) Net Equity Issued and Repurchased (2020 - 2025)

Ginkgo Bioworks Holdings' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $9.2 million for Q4 2025.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.9 million (up 75.51% YoY) and the FY2025 annual result came in at $19.5 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased was $9.2 million for Q4 2025 at Ginkgo Bioworks Holdings, up from -$24.6 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $15.1 million in Q3 2021 and bottomed at -$24.6 million in Q4 2022.
• A 3-year average of -$1.6 million and a median of $7.6 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased surged 83.43% — and 2022, when it tumbled 63.1%.
• Ginkgo Bioworks Holdings' Net Equity Issued and Repurchased stood at -$15.1 million in 2021, then slumped by 63.1% to -$24.6 million in 2022, then jumped by 137.19% to $9.2 million in 2025.
• Business Quant data shows DNA's Net Equity Issued and Repurchased at $9.2 million in Q4 2025, -$24.6 million in Q4 2022, and $7.6 million in Q3 2022.